TCG Crossover
Palo Alto, Californiatcgx.com
Overview
TCG Crossover is a healthcare investment firm that invests in both private and public companies developing disruptive medicines and better treatment options for patients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ollin Biosciences | Jun 2026 | Series B | Lead |
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
| Adcendo | Apr 2026 | Series C | Co-investor |
| LB Pharmaceuticals | Sep 2025 | IPO | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
